VT Ablation · EP Patient Education Library

Why we ablate VT

Ventricular tachycardia (VT) is a fast rhythm that arises from the lower chambers of the heart — the pumping chambers themselves. Unlike SVT, VT can be life-threatening because the heart is no longer filling and ejecting normally, and sustained VT can degenerate into ventricular fibrillation and cardiac arrest. Even when VT is not immediately life-threatening, repeated episodes are exhausting, drain quality of life, and, in patients with an ICD, lead to shocks that are physically and emotionally difficult to live with.

Ablation gives us a way to attack the problem at its source rather than continuing to suppress it with medications or wait for the next ICD therapy.

Two very different categories

Almost everything about the procedure — strategy, length, risk, expected outcome — depends on which category of VT we’re dealing with.

Idiopathic VT (structurally normal heart)

In some patients, VT comes from a single focal source in an otherwise healthy heart. The two classic locations are the right ventricular outflow tract (RVOT) and the fascicles of the left bundle branch (fascicular VT). Both have characteristic ECG patterns that often let us predict the location before we even start. These VTs are usually well-tolerated, and ablation success rates are excellent — comparable to SVT ablation when the focus can be mapped clearly.

Scar-mediated VT

In patients with prior myocardial infarction or with a non-ischemic cardiomyopathy (NICM), VT typically arises from circuits that loop around or through regions of scar in the ventricle. Surviving muscle fibers that thread through scar conduct slowly, and that slow conduction sets up the conditions for a reentrant circuit. The challenge here is that the substrate is large, diffuse, and sometimes accessible only from outside the heart. Procedures are longer, more complex, and outcomes are measured in terms of how much we reduce VT burden rather than absolute cure.

How we map

We use two complementary approaches.

Activation mapping

When the VT is hemodynamically tolerated, we induce it and map the chamber while the arrhythmia is running. The point of “earliest activation” — the spot the electrical wave appears to be emerging from — tells us where the focus is, or where the critical exit of a reentry circuit lives. We then deliver ablation there.

Substrate mapping

When VT is too unstable to map directly, we work in sinus rhythm and instead build a detailed voltage map of the chamber. Healthy muscle shows high-voltage signals; dense scar shows nothing; the borderlands in between — areas of low-voltage, fragmented, or late electrograms — are where reentry circuits live. We ablate those borderlands and channels to disconnect the circuits even without inducing the VT directly. Modern programs lean heavily on substrate mapping, especially for scar-mediated VT.

Endocardial versus epicardial

Most ablations are done from inside the chamber (endocardial). In some patients — particularly NICM, certain genetic cardiomyopathies, and right-sided VTs — the responsible circuit sits on the outer surface of the heart. We then access the pericardial space through a careful puncture below the breastbone and map and ablate from the epicardial side. Epicardial access adds specific risks (bleeding, injury to coronary arteries or phrenic nerve) and requires surgical backup.

The procedure step by step

You’ll be under general anesthesia. We place catheters through the femoral veins, and for left-ventricular work we add a femoral arterial sheath. After detailed mapping, we deliver radiofrequency energy at the targets — sometimes dozens of lesions to fully homogenize a scar region. We test by attempting to induce VT again at the end. The procedure is long — typically 4–6 hours — because both mapping and ablation take time, and because we frequently work in patients with advanced underlying heart disease who require careful management.

Recovery and follow-up

Patients usually stay overnight, and longer if mechanical support was used or if heart-failure adjustments are needed. We interrogate any existing ICD before discharge and tune detection settings. Follow-up includes device checks, repeat imaging in some cases, and continued attention to the underlying heart disease — because in scar-mediated VT, the disease that created the scar in the first place hasn’t gone away.

When we’d choose another option

For idiopathic VT that is rare and well-tolerated, a daily beta-blocker or calcium channel blocker may be all that’s needed. For scar-mediated VT, ICD therapy plus medication is the long-standing approach, and ablation is added when episodes become frequent, when shocks accumulate, or when medications stop working or become intolerable. Sympathetic modulation procedures are reserved for the most refractory cases.

Watch

Short videos to help illustrate this topic. Embedded from the original channels — content belongs to them.

Video pending Add a youtube video ID to display: Substrate mapping for scar-mediated VT

Substrate mapping for scar-mediated VT · Manufacturer animation (Abbott EnSite / Biosense Webster Carto) · Add a short clip showing substrate mapping in post-infarct VT.

Video pending Add a youtube video ID to display: RVOT (outflow tract) VT ablation overview

RVOT (outflow tract) VT ablation overview · Academic EP channel (Cleveland Clinic / Mayo) · Add an idiopathic-VT mechanism and ablation overview.

Informed Consent — At a Glance

A plain-English summary of what we discuss before this procedure. This is not a substitute for the formal consent conversation with Dr. Colombowala.

Benefits

✓For idiopathic VT (RVOT, fascicular), high cure rates and freedom from daily medications.
✓For scar-mediated VT, significant reduction in VT episodes and ICD shocks — improving quality of life and reducing hospitalizations.
✓Allows many patients to reduce or stop antiarrhythmic medications such as amiodarone.
✓Improves overall outcomes when VT is causing repeated ICD shocks or recurrent hospitalizations.

Risks

⚠Bleeding, bruising, or vascular injury at the groin access sites (~1–2%).
⚠Cardiac tamponade — fluid around the heart from perforation (~1–2%, higher with epicardial access).
⚠Stroke or TIA (~1%); higher than for right-sided procedures because we usually work in the left ventricle.
⚠Damage to the conduction system requiring a pacemaker (uncommon).
⚠Damage to nearby structures such as the coronary arteries, phrenic nerve, or esophagus (rare, mitigated by careful pre-procedure imaging).
⚠Hemodynamic instability during induced VT, sometimes requiring temporary mechanical support.
⚠Recurrence requiring repeat ablation, especially in scar-mediated VT (20–40% over 1–2 years).
⚠Death — uncommon (<1%) but higher than in other ablation procedures because patients often have advanced underlying heart disease.

Alternatives

↔Continued antiarrhythmic medication (most commonly amiodarone, sotalol, or mexiletine).
↔ICD therapy alone — treating VT episodes as they occur rather than preventing them.
↔Adjusting heart-failure therapy and treating the underlying cardiomyopathy.
↔Sympathetic nerve modulation (stellate ganglion block or cardiac sympathetic denervation) in selected refractory cases.
↔Observation for very rare, well-tolerated episodes of idiopathic VT.

During the procedure

You'll be under general anesthesia, often with an arterial line and sometimes with temporary mechanical circulatory support standing by. We access the femoral veins and, for left-sided work, the femoral artery as well. We map the ventricle in detail — both during sinus rhythm to identify scar, and during induced VT when safe — then deliver radiofrequency energy at the targets. In some patients we access the outside surface of the heart through a small puncture below the breastbone to ablate from the epicardium.

Recovery

You'll spend the night in the hospital, often in a step-down or ICU bed for monitoring. Bed rest for several hours is required if arterial access was used. Most patients go home in 1–2 days. Light activity for the first week, no heavy lifting or strenuous exercise for at least 1–2 weeks. We arrange close follow-up with device interrogation if you have an ICD, plus repeat imaging in selected cases.